Stockscreener 앱 받기
32.62
1.27%
0.41
시간 외 거래:
32.62
전일 마감가:
$32.21
열려 있는:
$32.57
하루 거래량:
870.06K
Relative Volume:
1.05
시가총액:
$1.80B
수익:
$2.00B
순이익/손실:
$-119.19M
주가수익비율:
-14.89
EPS:
-2.19
순현금흐름:
$-61.88M
1주 성능:
+3.62%
1개월 성능:
-16.53%
6개월 성능:
-18.55%
1년 성능:
-41.24%
1일 변동 폭
$31.67
$32.93
1주일 범위
$30.61
$32.93
52주 변동 폭
$29.32
$56.43
Enovis Corp Stock (ENOV) Company Profile
명칭
Enovis Corp
전화
(302) 252-9160
주소
2711 CENTERVILLE ROAD, WILMINGTON
ENOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
32.62 | 1.80B | 2.00B | -119.19M | -61.88M | -2.19 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-03 | 개시 | JMP Securities | Mkt Outperform |
| 2024-06-13 | 개시 | JP Morgan | Neutral |
| 2024-02-13 | 개시 | Stephens | Overweight |
| 2024-01-22 | 개시 | UBS | Buy |
| 2024-01-03 | 개시 | William Blair | Outperform |
| 2023-12-15 | 재확인 | Needham | Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-06-26 | 개시 | Needham | Buy |
| 2023-05-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-11 | 개시 | Goldman | Buy |
| 2022-09-12 | 개시 | Canaccord Genuity | Buy |
| 2022-09-12 | 개시 | Evercore ISI | Outperform |
| 2022-06-28 | 개시 | Argus | Hold |
| 2022-06-27 | 재개 | Loop Capital | Buy |
| 2022-06-16 | 개시 | Wells Fargo | Equal Weight |
모두보기
Enovis Corp 주식(ENOV)의 최신 뉴스
Are Options Traders Betting on a Big Move in Enovis (ENOV) Stock? - TradingView
Enovis Names Damien McDonald as New CEO to Drive Next Growth Chapter - MSN
Enovis Corp to Host Q1 2025 Earnings Call and Webcast on May 8th - MSN
Reasons to Sell ENOV and 1 Stock to Buy Instead - Yahoo Finance
Commit To Purchase Enovis At $25, Earn 10.7% Annualized Using Options - Nasdaq
Enovis to Host First Quarter 2025 Results Conference Call on May 8th - The Manila Times
Enovis to Host First Quarter 2025 Results Conference Call on May 8th | ENOV Stock News - GuruFocus
Enovis Corporation to Host Investor Conference Call for Q1 2025 Financial Results on May 8th - Nasdaq
Q1 2025 Earnings Preview: Enovis Readies Major Investor Update with Live Presentation May 8 - Stock Titan
Enovis Announces Third Quarter 2024 Results - ADVFN
Enovis’s Strategic Initiatives and Acquisitions Drive Buy Rating - TipRanks
Enovis names McDonald as CEO - MSN
Enovis appoints Damien McDonald as CEO - MedTech Dive
Enovis Appoints Damien McDonald CEO, Reaffirms Q1 Guidance Amid Strategic Growth Push - insights.citeline.com
Canaccord maintains Buy rating and $75 target for Enovis stock - Investing.com Australia
Enovis Receives Buy Rating Amidst Strategic Leadership Change and Strong Financial Projections - TipRanks
Canaccord maintains Buy rating and $75 target for Enovis stock By Investing.com - Investing.com India
Enovis’s Promising Future: Buy Rating Backed by Strategic Leadership and Positive Financial Outlook - TipRanks
Enovis names Damien McDonald as new CEO starting May 12 By Investing.com - Investing.com Canada
Enovis (ENOV) Appoints New CEO and Confirms Revenue Forecast - GuruFocus
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Enovis (ENOV) and Auckland International Airport Limited (OtherACKDF) - The Globe and Mail
Enovis names Damien McDonald as CEO, succeeding Matt Trerotola - TipRanks
Strategic Leadership and Financial Stability Drive Buy Rating for Enovis - TipRanks
Enovis Appoints Damien McDonald as New CEO - TipRanks
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer - Ortho Spine News
Enovis Corporation Reiterats Earnings Guidance for the First Quarter of 2025 - MarketScreener
Former LivaNova CEO to take corner office at Enovis - MassDevice
Enovis names Damien McDonald as new CEO starting May 12 - Investing.com Australia
Enovis Names Damien McDonald as Chief Executive; Reaffirms Q1 Revenue Guidance - MarketScreener
Enovis Appoints Damien McDonald as Chief Executive Officer - citybiz
Enovis Announces Appointment Of Damien Mcdonald As Chief Executive Officer - MarketScreener
Enovis Announces Appointment Of Damien McDonald As Chief Executive Officer - MarketScreener
Medical Device Expert Takes Helm at Enovis: Former LivaNova CEO to Drive Growth - Stock Titan
Enovis Corporation (NYSE:ENOV) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down - The Globe and Mail
Enovis Showcases Innovative Foot and Ankle Solutions at ACFAS Conference - MSN
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025 - GlobeNewswire
Enovis, Foundation Surgical and J&J MedTech Named Winners of OMTEC® Awards, Honoring Excellence in Orthopedic Innovation - Ortho Spine News
Revolutionary Bunion Surgery System Leads Enovis's Major Product Launch at ACFAS 2025 - Stock Titan
Enovis : trade; Publishes 2024 Corporate Social Responsibility Report - MarketScreener
Enovis Corp (ENOV) Stock Price Up 1.77% on Mar 19 - GuruFocus.com
Enovis Plans Leadership Change - The Healthcare Technology Report.
Enovis CEO Matthew Trerotola Announces Retirement Plan - TipRanks
Enovis Corp (ENOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
자본화:
|
볼륨(24시간):